Quantcast

Latest JUPITER trial Stories

2009-02-23 07:00:00

Percentage of Clinicians Performing hsCRP Testing Will Increase Dramatically Over the Next Six Months, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, as a result of the JUPITER clinical trial, 65 percent of surveyed managed care organizations' (MCO) pharmacy directors say they will reimburse AstraZeneca's Crestor for...

2009-02-10 09:07:11

Patients with high cholesterol levels who continually take statins appear to have a lower risk of death over four to five years, regardless of whether they already have diagnosed heart disease, according to a report in the February 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.Statin drugs have been shown to have a beneficial effect on levels of low-density lipoprotein (LDL, or "bad") cholesterol, according to background information in the article. The benefits...

2009-01-14 13:01:00

American Heart Association rapid access journal report: Study highlights: A new analysis estimates more than 11 million older Americans could be newly eligible for statin therapy if findings from the JUPITER trial are adopted into guidelines. That could take the number of older adults eligible for statin therapy to over 44 million, or 80 percent of that population. The analysis highlights a public health challenge since, even under current treatment guidelines, fewer than half of older...

c761f27a2b5967b48b4bcbed5d2d74331
2009-01-14 08:22:01

New research shows that an additional 19 percent of men over the age of 50 and women over the age of 60 would benefit from taking statins, one of the top selling drugs in the world. Previous research, known as the Jupiter study and funded by AstraZeneca, found that the statin Crestor significantly reduced deaths, heart attacks and strokes in those with normal cholesterol levels but elevated levels of C-reactive protein, an indicator of arterial inflammation associated with serious heart...

2008-11-14 12:00:22

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- For the first time ever, a new study is providing direct evidence that cholesterol-lowering drugs called statins can prevent heart attacks, strokes and deaths among women. The study, released Sunday at the American Heart Association's conference in New Orleans, found that statins can cut heart attacks and strokes by about half -- even among people with normal cholesterol levels. About 40 percent of the study's participants were women, making...

2008-11-12 00:00:18

A U.S. study suggests the cholesterol drug rosuvastatin reduced heart attacks and strokes in patients with elevated C-reactive protein levels. The lipid-lowering statin, marketed as Crestor, reduced heart attacks by 54 percent in people who had normal cholesterol but elevated levels of high sensitivity C-reactive protein, researchers said Sunday at a meeting of the American Heart Association. The report was also published in the New England Journal of Medicine. "Compared to those who...

2008-11-11 12:00:26

NEW ORLEANS, Nov. 11 /PRNewswire-USNewswire/ -- A lipid-lowering drug reduced heart attacks by 54 percent in people who had normal cholesterol but elevated levels of high sensitivity C-reactive protein (hsCRP), according to a study presented at the American Heart Association Scientific Sessions 2008. Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Men and Women with Elevated Levels of C-Reactive Protein: the JUPITER Trial was presented as a late-breaking clinical trial....

2008-11-11 06:00:03

By Steve Sternberg NEW ORLEANS -- Using Crestor to prevent heart attacks and save lives in apparently healthy people would add nearly $10 billion a year to the nation's medical bill, according to calculations released Monday. Crestor's high cost was just one of many concerns that emerged as doctors began to grapple with the implications of a landmark study released Sunday. The study, called JUPITER, showed that using the potent cholesterol-lowering statin to treat people with normal...

2008-11-10 18:00:05

WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- WomenHeart today urged women to talk with their doctors about heart disease risk factors in light of new research demonstrating the impact of statin therapy (cholesterol-lowering drugs) on cardiovascular events in women. The study, called JUPITER, found that statin therapy prevents heart attacks, strokes and deaths in women - even those with normal cholesterol levels and no signs of heart disease. "These new findings underscore the importance...

21efc580c61c69f29ecc894cd9844cc81
2008-11-09 18:15:00

A large study has found the cholesterol pill Crestor significantly lowered the chance of death and heart attack among people with low cholesterol and no substantial risk factors for heart disease. The study, published online by the New England Journal of Medicine, provides the most compelling evidence to date for using a new test to identify those who may need treatment, said Dr. Elizabeth Nabel, director of the National Heart, Lung and Blood Institute.  Experts reviewing current...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related